These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
804 related articles for article (PubMed ID: 28235723)
1. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets. Baghbani F; Moztarzadeh F Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723 [TBL] [Abstract][Full Text] [Related]
2. Novel alginate-stabilized doxorubicin-loaded nanodroplets for ultrasounic theranosis of breast cancer. Baghbani F; Moztarzadeh F; Mohandesi JA; Yazdian F; Mokhtari-Dizaji M Int J Biol Macromol; 2016 Dec; 93(Pt A):512-519. PubMed ID: 27601134 [TBL] [Abstract][Full Text] [Related]
3. Ultrasonic nanotherapy of breast cancer using novel ultrasound-responsive alginate-shelled perfluorohexane nanodroplets: In vitro and in vivo evaluation. Baghbani F; Chegeni M; Moztarzadeh F; Mohandesi JA; Mokhtari-Dizaji M Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():698-707. PubMed ID: 28532082 [TBL] [Abstract][Full Text] [Related]
4. Novel ultrasound-responsive chitosan/perfluorohexane nanodroplets for image-guided smart delivery of an anticancer agent: Curcumin. Baghbani F; Chegeni M; Moztarzadeh F; Hadian-Ghazvini S; Raz M Mater Sci Eng C Mater Biol Appl; 2017 May; 74():186-193. PubMed ID: 28254284 [TBL] [Abstract][Full Text] [Related]
5. Formulation design, preparation and characterization of multifunctional alginate stabilized nanodroplets. Baghbani F; Moztarzadeh F; Mohandesi JA; Yazdian F; Mokhtari-Dizaji M; Hamedi S Int J Biol Macromol; 2016 Aug; 89():550-8. PubMed ID: 27177456 [TBL] [Abstract][Full Text] [Related]
6. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
7. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system. Wang L; Wang W; Rui Z; Zhou D Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435 [TBL] [Abstract][Full Text] [Related]
8. Bifunctional alginate/chitosan stabilized perfluorohexane nanodroplets as smart vehicles for ultrasound and pH responsive delivery of anticancer agents. Gao Y; Ma Q; Cao J; Shi Y; Wang J; Ma H; Sun Y; Song Y Int J Biol Macromol; 2021 Nov; 191():1068-1078. PubMed ID: 34600955 [TBL] [Abstract][Full Text] [Related]
9. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer. Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819 [TBL] [Abstract][Full Text] [Related]
10. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer. Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174 [TBL] [Abstract][Full Text] [Related]
11. Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy. Ma W; Guo Q; Li Y; Wang X; Wang J; Tu P Eur J Pharm Biopharm; 2017 Mar; 112():209-223. PubMed ID: 27913127 [TBL] [Abstract][Full Text] [Related]
12. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles. Wang J; Ma W; Tu P Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672 [TBL] [Abstract][Full Text] [Related]
13. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment. Cui T; Zhang S; Sun H Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466 [TBL] [Abstract][Full Text] [Related]
14. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587 [TBL] [Abstract][Full Text] [Related]
15. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine. Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129 [TBL] [Abstract][Full Text] [Related]
16. Preparation of novel curcumin-loaded multifunctional nanodroplets for combining ultrasonic development and targeted chemotherapy. Ji G; Yang J; Chen J Int J Pharm; 2014 May; 466(1-2):314-20. PubMed ID: 24657138 [TBL] [Abstract][Full Text] [Related]
17. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition. Gao M; Xu Y; Qiu L J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110 [TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and rhein loaded nanomicelles attenuates multidrug resistance in human ovarian cancer. Han NN; Li X; Tao L; Zhou Q Biochem Biophys Res Commun; 2018 Mar; 498(1):178-185. PubMed ID: 29317204 [TBL] [Abstract][Full Text] [Related]
19. Alginate/CaCO3 hybrid nanoparticles for efficient codelivery of antitumor gene and drug. Zhao D; Liu CJ; Zhuo RX; Cheng SX Mol Pharm; 2012 Oct; 9(10):2887-93. PubMed ID: 22894610 [TBL] [Abstract][Full Text] [Related]
20. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer. Li C; Ge X; Wang L Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]